Pharmaceutical Accountability Foundation

Home Tags AbbVie

Tag: AbbVie

AMSTERDAM, THE NETHERLANDS: In February 2023, the Pharmaceutical Accountability Foundation (PAF) filed a lawsuit against AbbVie Netherlands and AbbVie Inc (globally), alleging that the...
Friday, May 9 (09:30-12:30), Farma ter Verantwoording and AbbVie will meet at the Amsterdam District Court, Parnassusweg 280, 1076 AV Amsterdam (near Amsterdam Zuid...
The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to...
AbbVie's Humira pricing policy drained up to €1.2 billion from the Dutch healthcare system AMSTERDAM, NETHERLANDS: Today the Amsterdam District Court ruled that the lawsuit...
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had...
AMSTERDAM, THE NETHERLANDS: In February of 2023, the Pharmaceutical Accountability Foundation (PAF) brought a lawsuit against the company on the grounds that AbbVie had...
Version 15 November 2023 About Adalimumab/Humira and pricing issues AbbVie’s blockbuster drug Adalimumab (brand name: Humira) for the treatment of rheumatoid arthritis is one of the...
Download the original (Dutch) here: antwoorden-op-kamervragen-over-de-rechtszaak-van-stichting-farma-ter-verantwoording-tegen-farmaceut-abbvieDownload Download the English translation here: Answers-to-written-Parliamentary-questions-on-FtV-case-against-AbbVieDownload
The Pharmaceutical Accountability Foundation recently launched a court case against pharma-giant AbbVie for excessive pricing of blockbuster drug Humira (adalimumab). We received media attention...
AMSTERDAM, THE NETHERLANDS: The Pharmaceutical Accountability Foundation (PAF) today brought a lawsuit against pharmaceutical company AbbVie for unfair, excessive pricing practices on its blockbuster...